ENOV Q3 Deep Dive: Portfolio Streamlining and Innovation Drive Amid Margin Headwinds

finance.yahoo.com/news/enov-q3-deep-dive-portfolio-145548062.html

Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the full year’s revenue to be around $2.26 billion, close to analysts’ estimates. Its…

This story appeared on finance.yahoo.com, 2025-11-07 14:55:48.
The Entire Business World on a Single Page. Free to Use →